Dr. Eddrice McMullan praises Accuro for increasing first-attempt success rates and reducing needle passes and placement times, especially in patients with high BMI or scoliosis. “It’s genius,” she says, emphasizing its effectiveness when traditional methods fall short.
Recent Posts
- RIVANNA Crosses 100-patent Threshold: Estate Protects Shared Platform Spanning Multiple FDA-cleared Product Lines
- RIVANNA Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance
- The Inflection Point for Neuraxial Guidance
- Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
- RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
